Stone Summit Wealth’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Stone Summit Wealth's AMGN Position: Q3 2026 in Review
Stone Summit Wealth reduced its Amgen (AMGN) stake by 2.2% in Q3 2026, selling an estimated $19.5K and leaving 2,226 shares worth $938K. The position accounts for 0.25% of the portfolio, ranked #67.
Stone Summit Wealth first reported a position in AMGN in Q1 2022 and has held it in 19 quarters since. 790 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Stone Summit Wealth held 2,226 shares of Amgen worth $938K as of Q3 2026.
- Stone Summit Wealth sold 49 Amgen shares in Q3 2026, an estimated $19.5K.
- Amgen made up 0.25% of Stone Summit Wealth's portfolio in Q3 2026, its #67 holding.
- Stone Summit Wealth first reported a position in Amgen in Q1 2022 and has held it in 19 quarters since.
- 790 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Stone Summit Wealth's 13F filing for Q3 2026, filed 14 Oct 2026.